Phase 1 Peripheral Neuropathy Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells Exosomes for Trigeminal Neuralgia

Peripheral NeuropathyTrigeminal Neuralgia

The Foundation for Orthopaedics and Regenerative Medicine20 enrolled1 locationNCT05152368

Not Yet Recruiting

Phase 1

A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Safety, Tolerability and Pharmacokinetic Study of Topical Pirenzepine in Healthy Volunteers

Diabetic Peripheral Neuropathy

WinSanTor Australia Pty Ltd24 enrolled1 locationACTRN12617000535370